Cosmetic manufacturers can sometimes violate the law by marketing a cosmetic product with a drug claim or marketing a drug product as a cosmetic, failing to comply with regulatory requirements for drugs. FDA has the authority to regulate cosmetic labeling claims.
On January 13, the FDA published the Interagency Working Group on Asbestos in Consumer Products IWGACP white paper, IWGACP Scientific Opinions on Testing Methods for Asbestos in Cosmetic Products Containing Talc including Talc Intended for Use in Cosmetics.